Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.38167
Abstract: Key Points Question Do patients with colorectal cancer (CRC) receive microsatellite instability and/or immunohistochemistry (MSI/IHC) tumor screening and germline genetic testing (GGT) when they have insurance that covers these tests? Findings In a cohort study… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.4170
Abstract: Key Points Question What is the association of germline cancer-predisposition variants (CPVs) with outcomes among children with rhabdomyosarcoma? Findings In this cohort study of 580 individuals aged 0.01-23.23 years with rhabdomyosarcoma, those with CPVs in… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.1489
Abstract: Pre‐emptive pharmacogenetics (PGx) testing of a panel of germline genetic variants represents a new model for personalized medicine. Clinical impact of PGx testing is maximized when all variant alleles for which actionable clinical guidelines are… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Human mutation"
DOI: 10.1002/humu.24374
Abstract: To avoid acquired variants found in the blood, cultured skin fibroblasts are a recommended DNA source for germline genetic testing in patients with hematologic disorders, but data are lacking regarding practicality and limitations. We conducted… read more here.
Sign Up to like & get recommendations! 0
Published in 2023 at "Journal of genetic counseling"
DOI: 10.1002/jgc4.1731
Abstract: Germline genetic evaluation is indicated for all patients with epithelial ovarian cancer (EOC). For testing to have clinical utility, results must be documented within the electronic medical record (EMR) and accessible to providers at the… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Immunity"
DOI: 10.1016/j.immuni.2021.01.011
Abstract: Understanding the contribution of the host's genetic background to cancer immunity may lead to improved stratification for immunotherapy and to the identification of novel therapeutic targets. We investigated the effect of common and rare germline… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "British Journal of Cancer"
DOI: 10.1038/s41416-024-02832-2
Abstract: Genetic testing to identify germline high-risk pathogenic variants in breast cancer susceptibility genes is increasingly part of the breast cancer diagnostic pathway. Novel patient-centred pathways may offer opportunity to expand capacity and reduce turnaround time.… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "South African Journal of Philosophy"
DOI: 10.1080/02580136.2025.2582107
Abstract: Germline genetic engineering (GGE) technologies enable us to modify the genetic material of organisms, including humans. Since using GGE on humans comes with major possible harms, its development and use should be regulated. How should… read more here.
Sign Up to like & get recommendations! 0
Published in 2023 at "Ophthalmic Genetics"
DOI: 10.1080/13816810.2023.2191707
Abstract: ABSTRACT Purpose To report the genotype and phenotype of a cohort of unselected uveal melanoma (UM) patients who had germline multi-gene panel genetic testing, including the BAP1 gene, from a large multi-ethnic cancer centre. We… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noae064.254
Abstract: Abstract BACKGROUND It is expected that 10-15% of children with CNS tumors have an underlying cancer predisposition syndrome (CPS). This has important implications on treatment, cancer screening and family counseling. There is no published data… read more here.